Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Pin to quick picksAKR.L Share News (AKR)

  • There is currently no data for AKR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK MIDDAY BRIEFING: Bank Of England Now Focused On Productivity

Fri, 24th Jan 2014 12:41

LONDON (Alliance News) - Bank of England Governor Mark Carney Friday signaled that rising productivity will now be the key factor that decides when the central bank will start to tighten monetary policy, and any tightening will be a slow, gradual process.

In a speech at the World Economic Forum in Davos, Carney effectively confirmed that the Forward Guidance the bank had previously given is no longer relevant after unemployment fell far faster than the central bank anticipated when the policy was introduced in August. He signaled that interest rate rises were still some way off because the rise in numbers in work wasn't being matched by increased productivity.

"It now seems likely that the rate of unemployment consistent with stable inflation in the medium term is somewhat lower than the (monetary policy committee) assessed back in August," the Governor told the Davos CBI British Business Leaders lunch.

Carney said he believes that factors including progress in the banking sector, the potential for skilled workers to return to higher-productivity jobs, and anticipated economies of scale, will boost productivity as the recovery continues, but he cautioned that the recovery will need to be sustained for longer if productivity is to grow "in earnest".

"Even though unemployment is falling faster than expected, the recovery has some way to run before it would be appropriate to consider moving away from the emergency setting of monetary policy," Carney said.

The Bank of England policy setters will adapt its Forward Guidance to "changing circumstances" in its February Inflation Report, the governor added.

"The MPC will consider a range of options to update our guidance, recognising both what we have learned about the behaviour of aggregate supply in the economy as well as the more benign inflation outlook," Carney said.

In corporate news, Royal Mail has reported a 2% increase in like-for-like revenues for the first half of the year, driven by continued growth in its parcels revenues. However, the company said parcel volumes were flat for the period as its new size-based pricing meant some customers decided not to send some larger items via Royal Mail.

Overall, like-for-like parcel revenues were up 8% over the nine months to end-December, driven by the new pricing structure, with parcels now accounting for 51% of group revenue. It said it handled 115 million parcels in December alone.

However, Royal Mail's overall revenues were also up 2% for the six months to the end of September, while parcel revenue growth at that stage was 9%, meaning that growth in that crucial business slowed in the Christmas quarter despite retailers reporting a boom in online sales.

Cairn Energy has become the latest company to be contacted by the Indian tax authorities, following in the wake of the likes of Vodafone Group, Royal Dutch Shell and IBM.

Cairn said it is now talking with the tax man about its accounts for the year to end-March, 2007, and is providing authorities with the necessary information. It said it has been instructed to keep hold of the 10.3% stake it still owns in Cairn India while the discussions take place.

In political news, tensions are rising in Egypt after a car bomb exploded outside a Cairo police headquarters and another bomb rocked a subway station in the Egyptian capital, killing at least five people, state media reported.

The Syrian government and the opposition are sitting at the negotiating table for the first time ever Friday in a bid to bring an end to the three-year-old conflict. They are meeting at the UN's offices in Geneva, where it is believed talks will centre on the release of prisoners and detainees and the possibility of opening besieged towns and villages to humanitarian aid deliveries. The two sides clashed openly over the conference's focus at a launch ceremony Wednesday in the Swiss town of Montreux.

Thailand's Constitutional Court has ruled that it is legal to postpone a general election scheduled for February 2. The court judges ruled that a postponement of the polls would not be a breach of the constitution. "The responsibility for postponing the elections lies jointly with both the prime minister and the chairman of the Election Commission," the court said. The Election Commission asked the court for a ruling in light of months of mass anti-government protests in Bangkok aimed at toppling the government of caretaker Prime Minister Yingluck Shinawatra.

Anti-government protesters in Ukraine have vowed to carry on their protests after President Viktor Yanukovych failed to make major concessions in late-night talks with opposition leaders. The promises came as the administration made another move likely to raise tensions. Yanukovych on Friday appointed his hardline Security Council Secretary Andriy Klyuyev as his new chief of staff. The president fired Serhiy Lyovochkin, who was regarded as relatively liberal, from the post January 17.

--------

FTSE 100: down 0.9% at 6,709.85
FTSE 250: down 1.5% at 15,737.50
AIM ALL-SHARE: down 0.8% at 863.94
GBP-USD: 1.6521
EUR-USD: 1.3710
GOLD: USD1,270.21 an ounce
OIL (Brent): USD106.70 a barrel

--------

KEY UK CORPORATE NEWS:

FTSE 100: Weir Group has won a USD98 million, or GBP59 million, two-year contract to provide general maintenance services on Lukoil's West Qurna-2 oilfield in southern Iraq. GlaxoSmithKline has received a recommendation for marketing authorisation for its Eperzan treatment for type 2 diabetes from the European Medicines Agency's Committee for Medical Products for Human Use. Shire has completed its tender off for the US's ViroPharma Inc, with 79.5% valid acceptances. BT Group will invest a further GBP50 million into its commercial fibre broadband programme over the next three years, with the goal of making high speed broadband available to more than 400,000 additional homes and businesses.

FTSE 250: Close Brothers Group is expecting a strong result for the first-half of its financial year, as the recovering economy boosted all three of its divisions. It said its positive first-quarter performance has so far carried on into the second quarter, adding that it is confident in its outlook for the full financial year. Workspace Group said its like-for-like rent roll increased 1.8% in the third quarter, and 7.6% to GBP56.7 million in the first nine months of its fiscal year. 3i Infrastructure said its European portfolio continued to perform well operationally and financially in its fiscal third quarter as it moves forward with its objective of paying a dividend of 5.5% of opening shareholders' equity for the full year. Essentra has now opened its new principal European components distribution facility in Kidlington in the UK, allowing to expand its product range and improve its next-day delivery process. Intellectual property business IP Group said the nanopore sequencing technology access programme carried out by its portfolio firm Nanopore Technologies Ltd was heavily oversubscribed.

AIM: Victoria Oil & Gas is a big gainer after it signed a settlement agreement with RSM Production Corp in relation to its cash-call dispute for the Logbaba gas project in Cameroon. Victoria said that the parties have agreed to an independent audit to determine the final balance payable by, or to be refunded to, RSM. ITM Power is up after it won a contract with AMEC and National Grid to assess efficient usage of Power-to-Gas energy storage. Stadium Group is doing well after it said it had delivered "significantly improved" profits in the second half as it began to see benefits from its restructuring programme. President Energy is another gainer after the results of an independent audit of its prospective resources came in substantially better than expected. The company said its three drilling target prospect areas in Paraguay are now estimated to have a gross mean unrisked prospective resource of 1.09 billion barrels of oil equivalent, more then double the 500 million barrels it had predicted. Stellar Resources is also up after the Gold Mines of Wales venture in which it owns a 49.9% stake, agreed a 12-month extension to its exclusive option agreement with the Crown Estates. Strategic Minerals is a big faller. It experienced a 94% increase in its share price in the week between January 15 and January 22, but said it knows of no reason for Friday's sharp drop. Akers Biosciences is down after it recommenced trading following its announcement of the price for its upcoming public offering on NASDAQ. E-Therapeutics is another faller after it announced the temporary halt of recruitment into ETS2101 cancer trials because of a drug supply issue. Biome Technologies is down after it said it expects to meet forecasts for its full-year results, but warned that its Stanelco RF Technologies business had seen a subdued end to the year due to turbulence in the Chinese fibre optic market.

--------

AFTERNOON WATCHLIST: World Economic Forum, Davos.

--------

Monday's Key UK Corporate Events

Apr Energy Trading statement
Whitbread Trading statement
Porvair Full Year Results
Aveva Interim Management Statement

-------

Monday's Key Economic Events

07:00 UK Nationwide Housing Prices
09:00 Germany IFO
15:00 US New Home Sales
15:30 US Dallas Fed Manufacturing Business Index

-------

By Steve McGrath; steve.mcgrath@alliancenews.com; @stevemcgrath1

Copyright © 2014 Alliance News Limited. All Rights Reserved.

More News
25 Jun 2014 11:44

UK WINNERS & LOSERS: REIT's Rise On Carney Message, Sector Activity

Read more
25 Jun 2014 11:33

Akers Biosciences Inks Distribution Agreement With Medline Industries

Read more
4 Jun 2014 11:11

Akers Biosciences Inks Sales And Distribution Agreement With Typenex

LONDON (Alliance News) - Akers Biosciences Inc said Wednesday that it had inked a sales and distribution agreement with Typenex Medical LLC for its PIFA Heparin/PF4 and PIFA PLUSS Platelet Factor 4 test kits. Akers said that the agreement was part of its strategy to accelerate sales of the

Read more
4 Jun 2014 08:09

Akers Biosciences signs distribution deal with US sales firm

Akers Biosciences, which manufactures rapid diagnostic screening and testing products, has entered into a sales and distribution agreement with US-based Typenex Medical, a product development and sales organisation. Under the contract, which can be renewed after one year by mutual consent, the gro

Read more
4 Jun 2014 07:25

UK MORNING BRIEFING: Tesco Reports Sales Decline Amid Price Cutting

LONDON (Alliance News) - UK shares have opened mostly lower, with small-caps slightly outperforming Wednesday ahead of the Queen's Speech and further European economic data.

Starting the trading day on a negative note, Tesco PLC reported a sharp drop in sales in the

Read more
16 May 2014 11:33

Akers Biosciences Inks India Marketing Agreement With Jai Capital

LONDON (Alliance News) - Akers Biosciences Inc said Friday that it had inked an agreement with Nevada-based Jai Capital LLC to market its rapid test products in India. Under the agreement Jai will market Aker's PIFA Heparin/Platelet Factor-4 Rapid Assay test for thrombosis, its PIFA Dengue

Read more
16 May 2014 08:05

Akers Biosciences to launch new product in India

AIM-listed healthcare equipment firm Akers Biosciences has entered into an agreement with medical devices market developer Jai Capital to launch the group's PIFA Heparin/Platele in India. The Nevada-based group will market the company's product to the Indian military, which is allowed to buy produc

Read more
14 May 2014 11:14

Akers Biosciences Profit Hit By IPO Costs, But Revenue More Than Doubles

LONDON (Alliance News) - Akers Biosciences Inc, which recently listed on Nasdaq, Wednesday reported a first-quarter net loss of USD595,600, mainly due to the costs of the initial public offering. The maker of rapid diagnostic screening and testing products, which is also listed on London's

Read more
7 May 2014 11:19

Akers Biosciences Adds New Distributor For Diseases Tests

LONDON (Alliance News) - Akers Biosciences Inc Wednesday said it had signed a deal whereby Dubai-based Thirty Six Strategies General Trading LLC will sell Akers' infectious diseases tests exclusively for the next three years in some countries. In a statement, Akers said the exclusive agreem

Read more
7 May 2014 10:54

Akers Biosciences arranges Australia and UAE distribution deal

AIM- and Nasdaq-listed healthcare equipment firm Akers Biosciences has signed a three-year distribution agreement to sell its products in Australia, Singapore, the United Arab Emirates and Oman. Dubai-based procurement company, 36S, will immediately begin marketing Aker's PIFA PLUSS infectious dis

Read more
30 Apr 2014 14:19

Akers Biosciences Begins Trial For Chlamydia Assay

LONDON (Alliance News) - Akers Biosciences Inc said Wednesday that it has begun clinical trials in the US for its PIFA PLUSS chlamydia assay, a test for chlamydia diagnosis using a finger stick blood sample. The study will include 200 to 250 patients in total, including normal, newly infect

Read more
28 Mar 2014 12:38

Akers Biosciences Loss Narrows As Breathalysers Boost Revenues

LONDON (Alliance News) - Akers Biosciences Inc Friday posted a narrowed pretax loss for 2013, as it saw revenues more than double, driven by sales of its breathalyser products, and expressed confidence for 2014 following its dual listing in New York in January. The company posted a pretax l

Read more
12 Mar 2014 17:23

Akers Biosciences CEO To Step Down

LONDON (Alliance News) Akers Biosciences Wednesday said Chief Executive Thomas Nicolette will step down from the board and leave the company on March 28. Nicolette, who has been at the helm since 2008, will be replaced by Executive Chairman Raymond Akers. The stock closed at 340.00 pe

Read more
24 Jan 2014 10:58

UK WINNERS & LOSERS: Cairn Falls As Indian Tax Department Gets In Touch

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Friday. ------- FTSE 100 - WINNERS Weir Group, up 0.2%. The engineering company said it had won a USD98 million, or GBP59 million, two-year contract to provide

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.